2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Cdx-1127: new trials by email Literature Review of Cdx-1127 trials Research Report on Cdx-1127
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC Atezolizumab 1200 MG in 20 ML Injection, Stereotactic Body Radiation Therapy, Varlilumab 3 mg/kg - Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 1 | Terminated | Rutgers, The State University of New Jersey | 16 | 2019-09-11 | 2026-02-05 |
| A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) IMA950, poly-ICLC, Varlilumab - Glioma, Malignant Glioma | Phase 1 | Terminated | Nicholas Butowski | 14 | 2017-04-03 | 2024-06-14 |
Astrocytoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Glioma (1) · Lung Neoplasms (1) · Lymphoma, Follicular (1) · Oligodendroglioma (1)
Nicholas Butowski (1) · Rutgers, The State University of New Jersey (1)
United States (2)
Hideho Okada, MD, PhD (1) · Jyoti Malhotra (1) · Nicholas Butowski, MD (1) · Salma Jabbour (1)
P30CA072720 (1), R21CA233856 (1)